Clinical Trials on Frown Lines
Total 413 results
-
Pacira CryoTech, Inc., a wholly owned subsidiary...CompletedGlabellar Frown Lines | Frown LinesUnited States
-
Pacira CryoTech, Inc., a wholly owned subsidiary...CompletedGlabellar Frown Lines | Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown Lines | Canthal LinesUnited States
-
ATGC Co., Ltd.RecruitingGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
Galderma R&DActive, not recruitingGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesUnited States, Canada
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown LinesRussian Federation
-
Huons Co., Ltd.UnknownGlabellar Frown LinesKorea, Republic of
-
Revance Therapeutics, Inc.CompletedFrown LinesUnited States, Canada
-
Croma-Pharma GmbHHugelCompletedFrown LinesUnited States, Austria, Canada
-
Bonti, Inc.CompletedGlabellar Frown Lines (GL)United States
-
Protox Inc.Not yet recruitingGlabellar Frown Lines
-
Protox Inc.CompletedGlabellar Frown LinesKorea, Republic of
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
IpsenCompleted
-
Revance Therapeutics, Inc.CompletedEfficacy and Safety of DaxibotulinumtoxinA for Injection to Treat Moderate to Severe Glabellar LinesGlabellar Frown LinesUnited States, Canada
-
Medy-ToxCompletedGlabellar Frown LinesAustralia
-
ATGC Co., Ltd.CompletedGlabellar Frown LinesKorea, Republic of
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.CompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedGlabellar Frown LinesUnited States
-
Evolus, Inc.PPDCompletedA Phase III Study to Demonstrate the Safety and Efficacy of DWP-450 to Treat Glabellar Lines - EV001Glabellar Frown LinesUnited States
-
Revance Therapeutics, Inc.CompletedGlabellar Frown LinesCanada
-
AllerganCompletedGlabellar Frown LinesUnited States
-
Merz Pharmaceuticals GmbHCompletedGlabellar Frown LinesUnited Kingdom, Germany, Austria
-
Evolus, Inc.AvaniaRecruitingGlabellar Frown LinesGermany
-
Eirion Therapeutics Inc.Active, not recruiting
-
Galderma R&DCompletedGlabellar Frown LinesGermany, United Kingdom
-
Medytox KoreaCompletedGlabellar Frown LinesKorea, Republic of
-
Evolus, Inc.ethica Clinical Research Inc.CompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States, Canada
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompletedGlabellar Frown LinesUnited States
-
Galderma R&DCompleted
-
Croma-Pharma GmbHCompletedGlabellar Frown Lines
-
Croma-Pharma GmbHCompletedGlabellar Frown Lines
-
EuBiologics Co.,LtdCompletedGlabellar Frown LinesKorea, Republic of
-
Croma-Pharma GmbHCompletedGlabellar Frown LinesUnited States
-
Medy-ToxUnknownGlabellar Frown LinesKorea, Republic of
-
Medy-ToxCompletedGlabellar Frown Lines
-
Merz Pharmaceuticals GmbHCompletedGlabellar Frown LinesGermany
-
Merz Pharmaceuticals GmbHCompletedGlabellar Frown LinesGermany
-
Galderma R&DCompletedGlabellar Frown Lines (GL) | Lateral Canthal Lines (LCL)United States, Canada